Stocks Health care OCS
NASDAQ · Health careOculis Holding AG (OCS)
It posted a net loss of CHF 99M. In fiscal 2025 capital spending exceeded operating cash flow by CHF 66.6M. At December 31, 2025 it held CHF 81.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 4, 2026.
What Oculis Holding AG does
Oculis Holding AG is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OCS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -CHF 99M | -CHF 1.89 | -CHF 66.6M |
| 2024 | n/a | -CHF 85.8M | -CHF 2.12 | -CHF 49.1M |
| 2023 | n/a | -CHF 88.8M | -CHF 2.97 | -CHF 55.1M |
| 2022 | n/a | -CHF 38.7M | -CHF 11.32 | -CHF 25.1M |
| 2022 | n/a | -CHF 18.6M | -CHF 5.84 | -CHF 13.9M |
| 2020 | n/a | -CHF 14.9M | -CHF 5.04 | -CHF 12M |
Latest SEC filings
What Oculis Holding AG has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 10, 2026
- August 6, 2026
- August 6, 2026
- June 25, 2026
- June 1, 2026
- May 14, 2026
- May 11, 2026
- April 29, 2026Passive stake changed SCHEDULE 13G/A
- April 21, 2026
- March 27, 2026Passive stake changed SCHEDULE 13G/A
Questions about OCS
What does Oculis Holding AG do?
Oculis Holding AG is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OCS.
Is Oculis Holding AG profitable?
No. In fiscal 2025 it reported a net loss of CHF 99M.
When did Oculis Holding AG last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 4, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from August 10, 2026.
Similar companies
Follow OCS
Get an email when Oculis Holding AG files with the SEC: results, executive changes, material agreements and annual reports.
Follow OCS: get an email when it filesWhere the numbers come from
Financial figures are the values Oculis Holding AG tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.